Concepedia

Elizabeth E. Kelly

EE

Statistics

Publications

6

Citations

99

H-Index

6

Active since

1986

Affiliations

AstraZeneca (United Kingdom)(Current)

Elizabeth E. Kelly is an author at AstraZeneca (United Kingdom) specializing in medicine, molecular pharmacology, and pharmacology.

Publications per year

1986–2018

6

Publications

6

Identification of pyrazolo-pyrimidinones as GHS-R1a antagonists and inverse agonists for the treatment of obesity

William McCoull, Peter Barton, Anders Broo et al. · MedChemComm · 2012 · 25 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Diacylglycerol kinase (DGKA) regulates the effect of the epilepsy and bipolar disorder treatment valproic acid in<i>Dictyostelium discoideum</i>

Elizabeth E. Kelly, Devdutt Sharma, Christopher J. Wilkinson et al. · Disease Models & Mechanisms · 2018 · 23 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Discovery, optimisation and in vivo evaluation of novel GPR119 agonists

Katy J. Brocklehurst, Anders Broo, Roger J. Butlin et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 15 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Statistical models of outcome in malpractice lawsuits involving death or neurologically impaired infants

Roy Bors-Koefoed, Samuel Zylstra, Laurence J. Resseguie et al. · The Journal of Maternal-Fetal Medicine · 1998 · 13 citations

Law, Obstetrics, Tort Law +9

Emergency ventricular pacing from the esophagus in infancy

Gerald A. Serwer, John M. Eckerd, Elizabeth E. Kelly et al. · The American Journal of Cardiology · 1986 · 12 citations

Medicine, Cardiology, Pediatrics +12

1–5 of 6